Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: a Markov model based on data from Serbia, country in socioeconomic transition.
Vojnosanitetski pregled. Military-medical and pharmaceutical review Feb, 2014 | Pubmed ID: 24665571